JPRN-UMIN000005931已完成未知
Clinical evaluation of 0.1% olopatadine hydrochloride ophthalmic solution in pediatric patients - Clinical evaluation of 0.1% olopatadine hydrochloride ophthalmic solution in pediatric patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 7years-old 至 16years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients having ocular itching sensation and injection (caused by disease other than allergic conjunctivitis) possibly affecting the evaluation of drug efficacy 2.Patients having retinal detachment, diabetic retinopathy or progressive retinal disease (excluding cases rated by the attending physician as causing no problem in enrollment to the study) 3.Patients with a history of ocular infection (bacterial, viral or fungal), corneal herpes or relapsing corneal erosion of sudden onset or secondary to corneal injury (excluding cases rated by the attending physician as causing no problem in enrollment to the study) 4.Patients having received continuous treatment with corticosteroid (subconjunctival injection) within 3 months (90 days) before acquisition of consent 5.Patients having received immunotherapy (desensitization, immunomodulating therapy, etc.) 6.Patients requiring continuous treatment of corticosteroid, immunosuppressors, non-steroidal anti-inflammatory agents, vasoconstrictors, anti-histamines, anti-allergy agents, herb preparations indicated for "conjunctivitis" or any ophthalmic solution other than the test product 7.Patients having undergone ocular laser therapy within 3 months (90 days) before acquisition of consent or non-laser ocular surgery within 6 months (180 days) after acquisition of consent or planned to receive surgery during the study period 8.Unilaterally blind patients (best corrected visual acuity: below 0.01) 9.Patients with a history of allergy or hypersensitivity to olopatadine hydrochloride 10.Patients necessitating the use of contact lens during the study period 11.Other patients judged by the attending physician as inappropriate for the study
研究者
相似试验
已完成
4 期
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric PatientsAllergic ConjunctivitisNCT01109485Alcon Research42
进行中（未招募）
1 期
Study of Olopatadine Hydrochloride Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Chinese SubjectsAllergic conjunctivitisMedDRA version: 20.0Level: LLTClassification code 10001709Term: Allergic conjunctivitisSystem Organ Class: 100000014962EUCTR2016-004317-27-Outside-EU/EEAAlcon China Ophthalmic250
尚未招募
不适用
nder-Recognition of Allergic conjunctivitis in Patients with Allergic Rhinitisallergic conjunctivitisEye - Diseases / disorders of the eyeAllergic rhinitisACTRN12612000143820A/Prof Peter Smith20
已完成
不适用
Impact of olopatadine hydrochloride(allelock(R)) against scratching behavior of atopic dermatitis patients at night.Atopic dermatitisJPRN-UMIN000010519Mie University, Graduate School of Medicine25
已完成
3 期
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese SubjectsAllergic ConjunctivitisNCT02322216Alcon Research383